| Literature DB >> 35410045 |
Marco Dettori1,2, Antonella Arghittu2, Paolo Castiglia1,2.
Abstract
Assessing knowledge, attitudes and behaviours towards vaccination is a key strategy when implementing national and international immunisation programmes aimed at improving compliance among the population and thereby increasing vaccination coverage. While vaccination's role as a powerful life-saving weapon in the fight against infectious diseases has been further highlighted following the introduction of the Coronavirus Disease 2019 (COVID-19) vaccine, there is still a discrepancy between the scientific evidence on the effectiveness of vaccines and the perception of the risk attributed to them. Known as "Vaccine Hesitancy" (VH), this phenomenon is the delay in acceptance or refusal of vaccines, despite the availability of services. VH can be found in at least 15% of the worldwide population, and even professional groups tasked with promoting vaccination as a primary prevention measure, e.g., healthcare workers (HCWs), sometimes have doubts regarding vaccination. Since 2014, this Public Health problem has been increasing in 90% of countries worldwide, to the extent that in 2019 it was listed as one of the ten greatest threats to global health by the World Health Organization (WHO). VH has also affected COVID-19 vaccination, hampering the achievement of desired vaccination coverage. Monitoring this trend by studying people's behaviour and attitudes could be a useful tool to aid Public Health, in orienting vaccination policies and designing new health education and continuous training interventions, aimed at both the general public and accountable cohorts, such as HCWs.Entities:
Keywords: COVID-19; SARS-CoV-2; emotional epidemiology; outrage management; vaccine hesitancy
Mesh:
Substances:
Year: 2022 PMID: 35410045 PMCID: PMC8999062 DOI: 10.3390/ijerph19074359
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Number and percentages of COVID-19 vaccination by age groups in Italy up to 11 February 2022. Source: Authors’ elaboration from Presidenza del Consiglio dei Ministri (Office of the Prime Minister) report [18].
| Age Groups | Population (a) | 1st Dose (b) | % 1st Dose | Single Dose (c) | Recovered (d) | % (b + c + d)/a | 2nd Dose (e) | Vaccinated (c + e) | % (c + e)/a | Booster | % * (f) | Awaiting 1st Dose | % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| 4,594,071 | 4,329,833 | 94.3 | 112,339 | 18,802 | 97.1 | 4,230,789 | 4,343,128 | 94.5 | 3,894,111 | 92.0 | 243,409 | 2.9 |
|
| 6,016,425 | 5,401,790 | 89.8 | 313,664 | 41,315 | 95.7 | 5,295,672 | 5,609,336 | 93.2 | 5,101,201 | 94.3 | 259,656 | 4.3 |
|
| 7,532,302 | 6,361,805 | 84.5 | 681,949 | 104,899 | 94.9 | 6,208,509 | 6,890,458 | 91.5 | 6,055,845 | 93.4 | 383,649 | 5.1 |
|
| 9,645,296 | 8,035,467 | 83.3 | 736,513 | 244,758 | 93.5 | 7,796,666 | 8,533,179 | 88.5 | 6,957,435 | 89.8 | 628,558 | 6.5 |
|
| 8,781,291 | 7,125,115 | 81.1 | 512,269 | 270,431 | 90.0 | 6,923,603 | 7,435,872 | 84.7 | 5,322,066 | 81.7 | 873,476 | 10.0 |
|
| 6,790,908 | 5,631,064 | 82.9 | 380,114 | 215,770 | 91.7 | 5,432,991 | 5,813,105 | 85.6 | 3,644,952 | 75.6 | 563,960 | 8.3 |
|
| 6,029,273 | 5,234,190 | 86.8 | 362,727 | 159,336 | 95.5 | 5,048,743 | 5,411,470 | 89.78 | 3,306,083 | 72.5 | 273,020 | 4.5 |
|
| 4,620,379 | 3,759,039 | 81.4 | 191,533 | 241,634 | 90.7 | 3,525,927 | 3,717,460 | 80.5 | 1,517,430 | 55.2 | 428,173 | 9.3 |
* % of the population potentially targeted for an additional or booster dose who have completed their vaccination cycle for at least four months.